The antibody-mediated rejection (AMR) market is growing steadily, driven by rising solid organ transplants and the demand for improved diagnostic assays, biologics, and plasma exchange therapies. Innovations in early detection and precision immunosuppression are key trends. https://www.datamintelligence.com/research-report/antibody-mediated-rejection-market